Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Subsidiary obtaining Sharp Healthcare shares

24th Feb 2017 10:22

RNS Number : 7977X
Hon Hai Precision Industry Co Ld
24 February 2017
 

No:1

Subject: Subsidiary Foxconn (Far East) Limited obtaining Foxteq Holdings Inc.

shares

Date of events:2017/02/24

Contents:

1.Name and nature of the subject matter (if preferred shares, the terms and conditions of issuance shall also be indicated, e.g.dividend yield):

Foxteq Holdings Inc. shares

2.Date of occurrence of the event:2017/02/24~2017/02/24

3.Volume, unit price, and total monetary amount of the transaction:

250,000,000 shares at USD0.1 each; total amount equals USD25,000,000

4.The manner in which the current transaction was decided, the reference basis for the decision on price, and the decision-making department:

Board of Directors

5.Current cumulative volume, amount, and shareholding percentage of holdings of the security being traded (including the current trade) and status of any restriction of rights (e.g.pledges):

8,469,237,880 sharesUSD846,923,788100%None

6.Current ratio of long or short term securities investment (including the current trade) to the total assets and shareholder's equity as shown in the most recent financial statement and the operating capital as shown in the most recent financial statement:

Ratio to total assets:11.5860%,to shareholder's equity:30.2268%

Operating Capital:NTD131,768,410,000

7.Concrete purpose or use of the acquisition or disposal:

Long Term Investment

 

No:2

Subject: Subsidiary Foxteq Holdings Inc. obtaining Fabrigene Limited shares

Date of events:2017/02/24

Contents:

1.Name and nature of the subject matter (if preferred shares, the terms and conditions of issuance shall also be indicated, e.g.dividend yield):

Fabrigene Limited shares

2.Date of occurrence of the event:2017/02/24~2017/02/24

3.Volume, unit price, and total monetary amount of the transaction:

25,000,000 shares at USD1 each; total amount equals USD25,000,000

4.The manner in which the current transaction was decided, the reference basis for the decision on price, and the decision-making department:

Board of Directors

5.Current cumulative volume, amount, and shareholding percentage of holdings of the security being traded (including the current trade) and status of any restriction of rights (e.g.pledges):

25,000,000 sharesUSD25,000,000100%None

6.Current ratio of long or short term securities investment (including the current trade) to the total assets and shareholder's equity as shown in the most recent financial statement and the operating capital as shown in the most recent financial statement:

Ratio to total assets:1.0437%,to shareholder's equity:2.7229%

Operating Capital:NTD131,768,410,000

7.Concrete purpose or use of the acquisition or disposal:

Long Term Investment

 

No:3

Subject: Subsidiary Fabrigene Limited obtaining Sharp Healthcare and Medical Company KY shares

Date of events:2017/02/24

Contents:

1.Name and nature of the subject matter (if preferred shares, the terms and conditions of issuance shall also be indicated, e.g.dividend yield):

Sharp Healthcare and Medical Company KY shares

2.Date of occurrence of the event:2017/02/24~2017/02/24

3.Volume, unit price, and total monetary amount of the transaction:

208,702,344 shares at USD0.1197 each; total amount equals USD25,000,000

4.The manner in which the current transaction was decided, the reference basis for the decision on price, and the decision-making department:

Board of Directors

5.Current cumulative volume, amount, and shareholding percentage of holdings of the security being traded (including the current trade) and status of any restriction of rights (e.g.pledges):

208,702,344 sharesUSD25,000,00051.2%None

6.Current ratio of long or short term securities investment (including the current trade) to the total assets and shareholder's equity as shown in the most recent financial statement and the operating capital as shown in the most recent financial statement:

Ratio to total assets:0.0302%,to shareholder's equity:0.0787%

Operating Capital:NTD131,768,410,000

7.Concrete purpose or use of the acquisition or disposal:

Long Term Investment

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFLIFAISFID

Related Shares:

Hon Hai Precsn
FTSE 100 Latest
Value8,875.22
Change0.00